Morningstar's Julie Stralow sees opportunities in both the debt and equity of medical device firms Stryker and Zimmer.
Core stock strategist Paul Larson highlights one recent pick in his StockInvestor Hare Portfolio, plus a super-wide-moat health-care firm for your watch list.
Morningstar's Brian Nelson reviews the performance of our corporate credit ratings on their one-year anniversary of their launch, plus two health-care bond picks.
If long-term investors can see beyond reform uncertainty, they could make a great return on Stryker shares.
Good morning. I'm Paul Blair, Vice President of Investor Relations for Zimmer. I'd like to welcome you to the Zimmer Fourth Quarter 2009 Earnings Conference Call.
Mr. Blair, you may begin your call.
Mr. Blair, you may begin your conference.
Sir, you may begin.
©2012 Morningstar Advisor. All right reserved.